A quick and easy test for detecting fentanyl in saliva
A Rapid, Sensitive and Instrument-free Oral Fluid Fentanyl Test
This study is working on a quick and easy test to check for fentanyl in saliva, which can help doctors respond faster in overdose cases and make sure people get the right care they need.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Instanosis, INC. NIH-funded |
| Lab location | 1 site (Milford, United States) |
| Project ID | NIH-11035399 on NIH RePORTER |
What this research studies
This research focuses on developing a rapid and sensitive test for detecting fentanyl in oral fluid, which can be crucial for timely medical intervention in overdose situations. The test aims to provide a non-invasive and easily administered method for identifying fentanyl, allowing for prompt administration of naloxone and appropriate clinical care. By utilizing a high-affinity anti-fentanyl antibody, the researchers are working to create a prototype that can be used in emergency settings and for drug compliance testing. The goal is to finalize the test design and ensure it is ready for widespread use.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk of fentanyl overdose, such as those with opioid use disorder or those in emergency medical situations.
Not a fit: Patients who are not at risk of fentanyl exposure or those who do not use opioids may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the ability to quickly identify fentanyl overdoses, potentially saving lives through timely treatment.
How similar studies have performed: Other research has shown success with similar rapid testing approaches for drug detection, indicating a promising avenue for this novel oral fluid test.
Where this research is happening
Milford, United States
- Instanosis, INC. — Milford, United States (Active)
Researchers
- Principal investigator: Xia, Xiaofeng — Instanosis, INC.
- Study coordinator: Xia, Xiaofeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.